Study examines attitudes toward long-acting injectable HIV therapy among women
Experts tap into behavioral research to promote COVID-19 vaccination in the US
7 January 2021Study reveals how one antibody blocks dangerous effects of dengue virus infection, offering potential path to prevention
7 January 2021Study examines attitudes toward long-acting injectable HIV therapy among women
A study led by Columbia University Mailman School of Public Health researchers examines attitudes toward long-acting injectable (LAI) HIV therapies, among women with a history of injection—including medical purposes and substance use. The findings appear in the journal AIDS Patient Care and STDs.
